Listed

Globus Medical Inc

GMEDNYSECIK 1237831HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$789.6m, Q2 FY2026
Operating income$182.4m, Q2 FY2026
Net income$151.6m, Q2 FY2026
Globus Medical Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m384Revenue, Q3 FY2023, three months to 2023-09-30$383.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure617Revenue, Q4 FY2023, three months to 2023-12-31$616.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure607Revenue, Q1 FY2024, three months to 2024-03-31$606.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure630Revenue, Q2 FY2024, three months to 2024-06-30$629.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure626Revenue, Q3 FY2024, three months to 2024-09-30$625.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure657Revenue, Q4 FY2024, three months to 2024-12-31$657.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure598Revenue, Q1 FY2025, three months to 2025-03-31$598.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure745Revenue, Q2 FY2025, three months to 2025-06-30$745.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure769Revenue, Q3 FY2025, three months to 2025-09-30$769.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure826Revenue, Q4 FY2025, three months to 2025-12-31$826.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure760Revenue, Q1 FY2026, three months to 2026-03-31$759.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure790Revenue, Q2 FY2026, three months to 2026-06-30$789.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Cost of revenue$m135Cost of revenue, Q3 FY2023, three months to 2023-09-30$135.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure265Cost of revenue, Q4 FY2023, three months to 2023-12-31$265.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure241Cost of revenue, Q1 FY2024, three months to 2024-03-31$241.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure260Cost of revenue, Q2 FY2024, three months to 2024-06-30$260.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure271Cost of revenue, Q3 FY2024, three months to 2024-09-30$270.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure263Cost of revenue, Q4 FY2024, three months to 2024-12-31$263.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure195Cost of revenue, Q1 FY2025, three months to 2025-03-31$195.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure249Cost of revenue, Q2 FY2025, three months to 2025-06-30$248.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure253Cost of revenue, Q3 FY2025, three months to 2025-09-30$252.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure261Cost of revenue, Q4 FY2025, three months to 2025-12-31$261.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure234Cost of revenue, Q1 FY2026, three months to 2026-03-31$234.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure241Cost of revenue, Q2 FY2026, three months to 2026-06-30$241.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Gross profit$m248Gross profit, Q3 FY2023, three months to 2023-09-30$248.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2023-11-07, accession 0001562762-23-000407.Report this figure351Gross profit, Q4 FY2023, three months to 2023-12-31$351.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-21, accession 0001562762-24-000032. Derived: 12-month figure less the 9-month figure.Report this figure365Gross profit, Q1 FY2024, three months to 2024-03-31$365.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-05-07, accession 0001562762-24-000126.Report this figure370Gross profit, Q2 FY2024, three months to 2024-06-30$369.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-08-06, accession 0001562762-24-000199.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m29.3Research and development, Q3 FY2023, three months to 2023-09-30$29.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure52.3Research and development, Q4 FY2023, three months to 2023-12-31$52.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure57.3Research and development, Q1 FY2024, three months to 2024-03-31$57.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure37.7Research and development, Q2 FY2024, three months to 2024-06-30$37.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure35.4Research and development, Q3 FY2024, three months to 2024-09-30$35.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure33.4Research and development, Q4 FY2024, three months to 2024-12-31$33.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure33.1Research and development, Q1 FY2025, three months to 2025-03-31$33.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure40.0Research and development, Q2 FY2025, three months to 2025-06-30$40.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure38.1Research and development, Q3 FY2025, three months to 2025-09-30$38.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure36.2Research and development, Q4 FY2025, three months to 2025-12-31$36.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure36.5Research and development, Q1 FY2026, three months to 2026-03-31$36.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure36.3Research and development, Q2 FY2026, three months to 2026-06-30$36.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Selling, general and administrative$m156Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$156.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure245Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$245.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure249Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$248.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure239Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$239.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure240Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$240.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure253Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$253.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure243Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$242.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure304Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$303.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure314Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$313.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure318Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$318.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure298Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$297.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure287Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$286.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Operating income$m0.4Operating income, Q3 FY2023, three months to 2023-09-30$404.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure10.1Operating income, Q4 FY2023, three months to 2023-12-31$10.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure8.0Operating income, Q1 FY2024, three months to 2024-03-31$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure49.6Operating income, Q2 FY2024, three months to 2024-06-30$49.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure48.1Operating income, Q3 FY2024, three months to 2024-09-30$48.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure60.3Operating income, Q4 FY2024, three months to 2024-12-31$60.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure97.0Operating income, Q1 FY2025, three months to 2025-03-31$97.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure76.1Operating income, Q2 FY2025, three months to 2025-06-30$76.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure137Operating income, Q3 FY2025, three months to 2025-09-30$137.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure169Operating income, Q4 FY2025, three months to 2025-12-31$169.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure150Operating income, Q1 FY2026, three months to 2026-03-31$150.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure182Operating income, Q2 FY2026, three months to 2026-06-30$182.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Income tax$m1.5Income tax, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure10.0Income tax, Q4 FY2023, three months to 2023-12-31$10.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure(1.4)Income tax, Q1 FY2024, three months to 2024-03-31−$1.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure15.8Income tax, Q2 FY2024, three months to 2024-06-30$15.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure5.2Income tax, Q3 FY2024, three months to 2024-09-30$5.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure(1.8)Income tax, Q4 FY2024, three months to 2024-12-31−$1.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure28.2Income tax, Q1 FY2025, three months to 2025-03-31$28.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure(14.7)Income tax, Q2 FY2025, three months to 2025-06-30−$14.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure25.0Income tax, Q3 FY2025, three months to 2025-09-30$25.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure28.6Income tax, Q4 FY2025, three months to 2025-12-31$28.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure32.8Income tax, Q1 FY2026, three months to 2026-03-31$32.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure38.2Income tax, Q2 FY2026, three months to 2026-06-30$38.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Net income$m1.0Net income, Q3 FY2023, three months to 2023-09-30$998.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure15.0Net income, Q4 FY2023, three months to 2023-12-31$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure(7.1)Net income, Q1 FY2024, three months to 2024-03-31−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure31.8Net income, Q2 FY2024, three months to 2024-06-30$31.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure51.8Net income, Q3 FY2024, three months to 2024-09-30$51.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure26.5Net income, Q4 FY2024, three months to 2024-12-31$26.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure75.5Net income, Q1 FY2025, three months to 2025-03-31$75.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure203Net income, Q2 FY2025, three months to 2025-06-30$202.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure119Net income, Q3 FY2025, three months to 2025-09-30$119.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure141Net income, Q4 FY2025, three months to 2025-12-31$140.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure124Net income, Q1 FY2026, three months to 2026-03-31$124.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure152Net income, Q2 FY2026, three months to 2026-06-30$151.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Diluted EPS$ per share0.01Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figurenot reported(0.05)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure0.23Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure0.38Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figurenot reported0.54Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure1.49Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure0.88Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figurenot reported0.90Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure1.10Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Basic EPS$ per share0.01Basic EPS, Q3 FY2023, three months to 2023-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figurenot reported(0.05)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure0.23Basic EPS, Q2 FY2024, three months to 2024-06-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure0.38Basic EPS, Q3 FY2024, three months to 2024-09-30$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figurenot reported0.55Basic EPS, Q1 FY2025, three months to 2025-03-31$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure1.50Basic EPS, Q2 FY2025, three months to 2025-06-30$1.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure0.88Basic EPS, Q3 FY2025, three months to 2025-09-30$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figurenot reported0.92Basic EPS, Q1 FY2026, three months to 2026-03-31$0.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure1.12Basic EPS, Q2 FY2026, three months to 2026-06-30$1.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure

Balance sheet

Cash and equivalents$507.7m, Q2 FY2026
Shareholders' equity$4.77bn, Q2 FY2026
Globus Medical Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reportednot reportednot reported784Cash and equivalents, FY2024, at 2024-12-31$784.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001628280-26-011209.Report this figurenot reportednot reportednot reported526Cash and equivalents, FY2025, at 2025-12-31$526.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure561Cash and equivalents, Q1 FY2026, at 2026-03-31$561.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure508Cash and equivalents, Q2 FY2026, at 2026-06-30$507.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Current assets$m1,917Current assets, Q3 FY2023, at 2023-09-30$1.92bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001562762-23-000407.Report this figure1,915Current assets, FY2023, at 2023-12-31$1.92bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-20, accession 0001562762-25-000026.Report this figure1,829Current assets, Q1 FY2024, at 2024-03-31$1.83bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001562762-24-000126.Report this figure1,924Current assets, Q2 FY2024, at 2024-06-30$1.92bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001562762-24-000199.Report this figure2,057Current assets, Q3 FY2024, at 2024-09-30$2.06bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure2,177Current assets, FY2024, at 2024-12-31$2.18bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-24, accession 0001628280-26-011209.Report this figure1,710Current assets, Q1 FY2025, at 2025-03-31$1.71bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure1,730Current assets, Q2 FY2025, at 2025-06-30$1.73bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure1,924Current assets, Q3 FY2025, at 2025-09-30$1.92bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure2,126Current assets, FY2025, at 2025-12-31$2.13bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure2,198Current assets, Q1 FY2026, at 2026-03-31$2.20bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure2,216Current assets, Q2 FY2026, at 2026-06-30$2.22bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Total assets$m5,356Total assets, Q3 FY2023, at 2023-09-30$5.36bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001562762-23-000407.Report this figure5,086Total assets, FY2023, at 2023-12-31$5.09bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-20, accession 0001562762-25-000026.Report this figure4,944Total assets, Q1 FY2024, at 2024-03-31$4.94bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001562762-24-000126.Report this figure4,994Total assets, Q2 FY2024, at 2024-06-30$4.99bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001562762-24-000199.Report this figure5,086Total assets, Q3 FY2024, at 2024-09-30$5.09bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure5,252Total assets, FY2024, at 2024-12-31$5.25bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001628280-26-011209.Report this figure4,711Total assets, Q1 FY2025, at 2025-03-31$4.71bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure4,961Total assets, Q2 FY2025, at 2025-06-30$4.96bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure5,096Total assets, Q3 FY2025, at 2025-09-30$5.10bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure5,303Total assets, FY2025, at 2025-12-31$5.30bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure5,440Total assets, Q1 FY2026, at 2026-03-31$5.44bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure5,488Total assets, Q2 FY2026, at 2026-06-30$5.49bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Current liabilities$m429Current liabilities, Q3 FY2023, at 2023-09-30$428.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001562762-23-000407.Report this figure392Current liabilities, FY2023, at 2023-12-31$392.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-20, accession 0001562762-25-000026.Report this figure786Current liabilities, Q1 FY2024, at 2024-03-31$786.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001562762-24-000126.Report this figure794Current liabilities, Q2 FY2024, at 2024-06-30$794.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001562762-24-000199.Report this figure818Current liabilities, Q3 FY2024, at 2024-09-30$818.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure856Current liabilities, FY2024, at 2024-12-31$855.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-24, accession 0001628280-26-011209.Report this figure385Current liabilities, Q1 FY2025, at 2025-03-31$384.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure425Current liabilities, Q2 FY2025, at 2025-06-30$424.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure466Current liabilities, Q3 FY2025, at 2025-09-30$466.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure498Current liabilities, FY2025, at 2025-12-31$498.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure482Current liabilities, Q1 FY2026, at 2026-03-31$482.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure479Current liabilities, Q2 FY2026, at 2026-06-30$479.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Total liabilities$m1,169Total liabilities, Q3 FY2023, at 2023-09-30$1.17bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001562762-23-000407.Report this figure1,088Total liabilities, FY2023, at 2023-12-31$1.09bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-20, accession 0001562762-25-000026.Report this figure1,021Total liabilities, Q1 FY2024, at 2024-03-31$1.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001562762-24-000126.Report this figure1,017Total liabilities, Q2 FY2024, at 2024-06-30$1.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001562762-24-000199.Report this figure1,017Total liabilities, Q3 FY2024, at 2024-09-30$1.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure1,074Total liabilities, FY2024, at 2024-12-31$1.07bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001628280-26-011209.Report this figure623Total liabilities, Q1 FY2025, at 2025-03-31$623.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure665Total liabilities, Q2 FY2025, at 2025-06-30$665.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure697Total liabilities, Q3 FY2025, at 2025-09-30$696.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure730Total liabilities, FY2025, at 2025-12-31$729.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure707Total liabilities, Q1 FY2026, at 2026-03-31$707.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure720Total liabilities, Q2 FY2026, at 2026-06-30$719.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure
Shareholders' equity$m4,187Shareholders' equity, Q3 FY2023, at 2023-09-30$4.19bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure3,998Shareholders' equity, FY2023, at 2023-12-31$4.00bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001628280-26-011209.Report this figure3,922Shareholders' equity, Q1 FY2024, at 2024-03-31$3.92bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure3,976Shareholders' equity, Q2 FY2024, at 2024-06-30$3.98bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure4,069Shareholders' equity, Q3 FY2024, at 2024-09-30$4.07bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure4,177Shareholders' equity, FY2024, at 2024-12-31$4.18bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure4,088Shareholders' equity, Q1 FY2025, at 2025-03-31$4.09bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure4,296Shareholders' equity, Q2 FY2025, at 2025-06-30$4.30bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure4,399Shareholders' equity, Q3 FY2025, at 2025-09-30$4.40bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure4,573Shareholders' equity, FY2025, at 2025-12-31$4.57bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure4,732Shareholders' equity, Q1 FY2026, at 2026-03-31$4.73bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure4,769Shareholders' equity, Q2 FY2026, at 2026-06-30$4.77bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure

Cash flow

Operating cash flow$209.7m, Q2 FY2026
Capital expenditure$33.2m, Q2 FY2026
Share repurchases$136.1m, Q2 FY2026
Globus Medical Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m50.5Operating cash flow, Q3 FY2023, three months to 2023-09-30$50.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0001562762-24-000254. Derived: 9-month figure less the 6-month figure.Report this figure105Operating cash flow, Q4 FY2023, three months to 2023-12-31$104.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure52.4Operating cash flow, Q1 FY2024, three months to 2024-03-31$52.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure54.3Operating cash flow, Q2 FY2024, three months to 2024-06-30$54.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001562762-25-000200. Derived: 6-month figure less the 3-month figure.Report this figure204Operating cash flow, Q3 FY2024, three months to 2024-09-30$203.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001237831-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure210Operating cash flow, Q4 FY2024, three months to 2024-12-31$210.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure177Operating cash flow, Q1 FY2025, three months to 2025-03-31$177.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure77.9Operating cash flow, Q2 FY2025, three months to 2025-06-30$77.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054450. Derived: 6-month figure less the 3-month figure.Report this figure250Operating cash flow, Q3 FY2025, three months to 2025-09-30$249.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001237831-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure249Operating cash flow, Q4 FY2025, three months to 2025-12-31$248.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure202Operating cash flow, Q1 FY2026, three months to 2026-03-31$202.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure210Operating cash flow, Q2 FY2026, three months to 2026-06-30$209.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054450. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m21.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$21.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0001562762-24-000254. Derived: 9-month figure less the 6-month figure.Report this figure22.9Capital expenditure, Q4 FY2023, three months to 2023-12-31$22.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure28.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$28.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure27.8Capital expenditure, Q2 FY2024, three months to 2024-06-30$27.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001562762-25-000200. Derived: 6-month figure less the 3-month figure.Report this figure42.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$42.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001237831-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure17.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$17.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure36.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$36.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure46.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$46.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054450. Derived: 6-month figure less the 3-month figure.Report this figure35.8Capital expenditure, Q3 FY2025, three months to 2025-09-30$35.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001237831-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure46.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$46.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure39.6Capital expenditure, Q1 FY2026, three months to 2026-03-31$39.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure33.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$33.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054450. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reported83.3Share repurchases, Q1 FY2024, three months to 2024-03-31$83.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure1.5Share repurchases, Q2 FY2024, three months to 2024-06-30$1.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-07, accession 0001562762-25-000200. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001237831-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure1.0Share repurchases, Q4 FY2024, three months to 2024-12-31$1.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure190Share repurchases, Q1 FY2025, three months to 2025-03-31$190.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure25.0Share repurchases, Q2 FY2025, three months to 2025-06-30$25.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001628280-26-054450. Derived: 6-month figure less the 3-month figure.Report this figure40.0Share repurchases, Q3 FY2025, three months to 2025-09-30$40.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001237831-25-000031. Derived: 9-month figure less the 6-month figure.Report this figure45.0Share repurchases, Q4 FY2025, three months to 2025-12-31$45.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-24, accession 0001628280-26-011209. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure136Share repurchases, Q2 FY2026, three months to 2026-06-30$136.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001628280-26-054450. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)137.38m, Q2 FY2026
Globus Medical Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares101Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30101,417,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001562762-23-000407.Report this figure102Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31102,196,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001562762-24-000126.Report this figure102Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30101,782,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001562762-24-000199.Report this figure115Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30115,245,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0001562762-24-000254.Report this figure135Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31135,358,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001562762-25-000118.Report this figure137Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30136,979,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001562762-25-000200.Report this figure138Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30138,062,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure140Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31139,774,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure136Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30136,499,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure135Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30135,394,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001237831-25-000031.Report this figure138Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31138,191,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628280-26-032290.Report this figure137Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30137,384,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure

Shares outstanding: 134.26mShares outstanding, period not labelled, at 2026-08-04134,261,914 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054450.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.